Related Experiment Video

Updated: Aug 3, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Monitoring signal transduction in cancer: tyrosine kinase gene expression profiling

H U Weier1, H F Zitzelsberger, H B Hsieh

  • 1Life Sciences Division, E.O. Lawrence Berkeley National Laboratory, University of California, 1 Cyclotron Road, MS 74-157, Berkeley, CA 94720, USA. ugweier@lbl.gov

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|April 17, 2001
PubMed

Insights

Researchers developed a rapid assay to measure tyrosine kinase (TK) gene expression in tumors. This method aids in identifying novel tumor progression markers and potential therapeutic targets for cancer intervention.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Expression Analysis

Background:

  • Abnormal tyrosine kinase (TK) gene expression is prevalent in tumors, influencing cell growth and responses to stimuli.
  • Dysregulation of TK genes, including receptor tyrosine kinases and mitogen-activated protein kinases, is implicated in thyroid and breast carcinomas.
  • Overexpression of TK genes can lead to oncogenic transformation of epithelial cells.

Purpose of the Study:

  • To develop a rapid and semiquantitative method for assessing the expression levels of 50-100 TK genes.
  • To identify TK genes with altered expression during malignant transformation and tumor progression.
  • To explore the potential of this assay in defining new tumor markers and therapeutic targets.

Main Methods:

  • Utilized RT-PCR with mixed-base primers targeting conserved regions in the TK gene catalytic domain.
  • Generated gene-specific fragments for subsequent analysis.
  • Employed DNA microarrays with known TK gene targets for hybridization of labeled PCR products.
  • Incorporated differentially labeled fragments from normal cells for comparative analysis.

Main Results:

  • Successfully developed a rapid scheme to semiquantitatively measure expression levels of numerous TK genes.
  • Demonstrated the ability to identify TK genes with altered expression in tumor samples compared to normal controls.
  • Provided examples showcasing the assay's utility in identifying potential markers and targets.

Conclusions:

  • The developed assay offers a novel approach for analyzing TK gene expression profiles.
  • This method can aid in the discovery of new biomarkers for tumor progression.
  • The findings suggest potential for identifying new therapeutic targets for cancer intervention.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...